We report a laser-based process for microstructuring glass materials for microfluidics applications. The hybrid technique is composed of a nanosecond Q-Switch Nd:YVO4 laser for fabricating the initial microfluidic microstructures on soda-lime glass substrates and a thermal treatment for reshaping and improving its morphological and optical qualities. The proposed technique preserves the advantages of the laser direct-write technique in terms of design flexibility, simplicity, fast prototyping, low cost, and so on. The beam spot size, pulse overlapping, ablation threshold, debris deposition, heating temperature, and time are investigated and optimized for fabricating optimal microfluidics structures on glass. The manufactured chips for circulating tumor cells (CTCs) capture were tested with tumor cells (Hec 1A) after being functionalized with an EpCAM antibody coating. Cells were successfully arrested on the pillars after being flown through the device giving our technology a translational application in the field of cancer research.
Part of the book: Advances in Microfluidics
This study investigates the biological response of zirconia/tantalum biocermet materials with laser-induced periodic surface structures (LIPSS) generated using a femtosecond laser working at 1030 nm wavelength. LIPSS were formed by laser radiation slightly above the applied threshold fluence. LIPSS features were characterized using techniques such as atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS). LIPSS were generated in this study by applying femtosecond pulses with 500 fs pulse duration at a high-repetition rate to smooth-polished zirconia/tantalum biocermet surfaces, with an original roughness value of 3.8 ± 0.2 and 3.1 ± 0.2 nm, respectively. We have demonstrated in vitro that LIPSS are an efficient option to increase osteoblastic differentiation of human bone marrow mesenchymal stem cells (hBMSCs) in ZrO2:Ta biocermets. LIPSS created increase cell metabolism statistically (best values in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay) and decrease inflammatory response to the material (IL-6 and TNF-alpha values). Extracellular matrix production (ECM) is produced in more quantity and cells differentiate to osteoblast easily. These differences are seen from the beginning until the endpoint (day 20).
Part of the book: Laser Ablation